Dechert Expands Dallas Footprint with Healthcare-Focused M&A Partner
Event summary
- Elaine Kao joins Dechert as a partner in its corporate and securities practice in Dallas, effective May 18, 2026.
- Kao specializes in M&A, joint ventures, and restructurings, particularly in healthcare, biotech, and professional services sectors.
- Dechert has added over 40 lateral partners in 2026, part of its strategy to bolster capabilities in key practice areas.
- The firm recently opened offices in Dallas and Houston to strengthen its Texas presence.
The big picture
Dechert's continued investment in its Texas footprint reflects the growing importance of Dallas as a hub for sophisticated corporate work. The firm's focus on lateral hires in specialized sectors like healthcare and biotech aligns with broader industry trends of consolidation and regulatory complexity in these areas. With over 40 new partners added this year, Dechert is positioning itself to compete more aggressively in high-value transactional work.
What we're watching
- Market Penetration
- How Dechert's expanded Dallas presence will impact its competitiveness against regional and national law firms.
- Talent Retention
- Whether Dechert can sustain its aggressive lateral hiring strategy amid industry-wide talent wars.
- Sector Focus
- The pace at which Dechert integrates Kao's expertise into its broader healthcare and biotech offerings.